Scientists have developed a new antibiotic, zosurabalpin, to attack a notoriously drug-resistant family of bacteria known as carbapenem-resistant Acinetobacter baumannii, or CRAB for short, which kills many of those it infects.

Sidney M. Wolfe, MD, who fought the FDA and pharmaceutical industry over high drug prices and dismissed health hazards for more than four decades, died at 86 years old, The New York Times reported. 

Pfizer will lay off more than a fourth of its employees at a New York facility, according to a WARN notice filed in the state. 

Children's Hospital Colorado did not have the resources to pay pharmacy techs more or create a training program, so it established apprenticeships to solve the workforce shortage. 

Since launching in January 2021 with about 100 generics, Mark Cuban Cost Plus Drug Co. now offers more than 2,000 drugs, including about a dozen brand-name medications. 

The FDA is warning clinicians and pharmacies about possible infection risks tied to counterfeit versions of the weight loss drug Ozempic. 

At the start of 2024, GSK is discontinuing Flovent, its popular branded asthma inhaler, and switching to a generic version. The generic is virtually identical, though physicians are worried that delays in securing insurance coverage will cause disruptions for patients, CNN reported Dec. 28. 

In an effort to expand its cancer treatment offerings, Bristol Myers Squibb plans to acquire RayzeBio, a radiopharmaceutical therapeutics company. The deal is worth $4.1 billion, the companies announced Dec. 26. 

In the face of modern challenges, expanding outpatient retail pharmacy services and exploring nontraditional partnerships present a growing opportunity for health systems to better patient outcomes, generate much-needed revenue, and safeguard themselves from added financial risk.

The number of overdoses from Ozempic and Wegovy nearly quadrupled between 2021 and 2023, according to poison center data reported by The Los Angeles Times.

Researchers at the University of California San Diego School of Medicine found positive results from a trial of a vaccine to treat acne in mice, the institution announced Dec. 20.

Rite Aid has entered a proposed settlement with the Federal Trade Commission to resolve allegations the drug store chain improperly used facial recognition technology to identify potential shoplifters.

Pfizer's COVID-19 antiviral Paxlovid cut the prevalence of hospitalizations and deaths in half when it was used within the first day of diagnosis, according to a study published Dec. 16 in Nature. 

Amid the rise of the Ozempic, Wegovy and Mounjarno, older weight loss drugs are making a comeback in 2023, just like ripped jeans.

A popular class of drugs for weight loss and Type 2 diabetes might help lower the prevalence of heart disease, according to a study published Dec. 18 in Cell Metabolism.

Chronic drug shortages are difficult to resolve because of multiple races to drive down prices on generics, The New York Times reported Dec. 19. 

The Novo Nordisk Foundation, the philanthropic arm of the Danish pharmaceutical giant, announced Dec. 18 that it has committed $260 million toward the development and improvement of respiratory virus vaccines. 

Georgia had been ramping up to become the first state to allow pharmacies to dispense medical cannabis. Now the Drug Enforcement Administration is warning pharmacies in the state that doing so would violate federal law.

Some patients taking Ozempic (semaglutide) are considering skipping doses to indulge during the winter holidays, but a short break in the regimen can spur health issues, according to a UCLA physician.

Bristol Myers Squibb is ending a phase 3 clinical trial of a combination treatment for metastatic colorectal cancer after an independent committee determined it was unlikely to produce meaningful results, the drugmaker said Dec. 15.